Laminitis (commonly called “founder”) affects an estimated 7-14% of the world’s equine population. It’s the inflammation of the tiny, interwoven lamellae that attach a horse’s hoof to the underlying coffin bone (third phalanx, or P3) and support the horse’s entire body weight. Anything that impacts the integrity of the lamellae, such as inflammation, weakens their hold. This causes the coffin bone to displace within the hoof capsule and move toward the ground. The condition is very painful and is often life-threatening to horses.
The same disease has several different causes, which include:
Learn why some horses are more likely to develop EMS and associated laminitis and how to tell if your horse is at risk.
Our equine nutrition expert offers a reader advice on how to feed a thin horse with a history of laminitis without causing another bout of the disease.
Manage at-risk horses’ diet and exercise to help avoid this painful condition.
Learn about the differences, and a few key similarities, between these two endocrine diseases.
The Type 2 diabetes drug might help horses with chronic hyperinsulinemia and laminitis that haven’t responded to management changes.
The overall incidence of laminitis due to IA corticosteroid injection might be lower than many believe.
Stay on top of the most recent Horse Health news with